Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin

Journal of Vascular Research

Volumn 43, Issue 2, 2006, Pages 131-138

  Honjo, Tomoyuki ^a   Inoue, Nobutaka ^a   Shiraki, Rio ^a   Kobayashi, Seiichi ^a   Otsui, Kazunori ^a   Takahashi, Motonori ^a   Hirata, Ken Ichi ^a   Kawashima, Seinosuke ^a   Yokozaki, Hiroshi ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelium; HMG CoA reductase inhibitors; Oxidative stress

Indexed keywords

ANGIOTENSIN II; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; PITAVASTATIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UROCORTIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME INHIBITION; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICROVASCULATURE; NORMAL HUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; UPREGULATION;

ADULT; ANTIOXIDANTS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; ENDOTHELIUM, VASCULAR; HUMANS; INTERFERON TYPE II; MALE; QUINOLINES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; UP-REGULATION;

EID: 32644490150     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090132     Document Type: Article

References (31)

1. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, River C: Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotrophin-releasing factor. Nature 1995;378:287-292.
2. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Totsune K, Suzuki H, Nagura H, Yoshimi T: Urocortin expression in human pituitary gland and pituitary adenoma. J Clin Endocrinol Metab 1997;82:3842-3850.
3. Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T: Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptide 1998;19:643-647.
4. Petraglia F, Florio P, Gallo R, Simoncini T, Saviozzi M, Di Blasio AM, Vaughan J, Vale W: Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 1996;81:3807-3810.
5. Chatzaki E, Charalampopolos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A: Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 2003;88:478-483.
6. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue K, Kusaka Y, Kubo T, Elenkov IJ, Chrousos G, Kondo M, Sano H: Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 2001;86:4344-4352.
7. Bamberger CM, Wald M, Bamberger AM, Ergun S, Beri FU, Schulte HM: Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 1998;83:708-711.
8. Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, Ehrhart-Bornstein M: Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 2004;89:965-970.
9. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H: Expression of urocortin and corticotrophin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 2002;87:340-346.
10. Rademaker MT, Charles CJ, Espiner E, Fisher S, Frampton CM, Kirkpatrick CMJ, Lainchbury J, Nicholls G, Richards M, Vale W: Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 2002;40:1495-1505.
11. + channels in endothelium- independent relaxation by urocortin in the rat coronary artery. Cardiovascular Research 2003;57:824-833.
12. Parkes DG, Vaughan J, Rivier J, Vale W, May CN: Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 1997;272:H2115-H2122.
13. Scarabelli TM, Pasini E, Stephanou A, Comini L, Curello S, Raddino R, Ferrari R, Knight R, Latchman D: Urocortin promotes hemodynamic and bioenergic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol 2002;40:155-161.
14. Gordon JM, Gregory JD, Owen LW, Dusting GJ, Woodman OL: Cardioprotective action of CRF peptide urocortin against stimulated ischemia in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2003;284:H330-H336.
15. ATP channel gene expression is induced by urocortin and mediates its cardioprotective effect. Circulation 2002;106:1556-1562.
16. Schulman D, Latchman DS, Yellon DM: Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol 2002;283:H1481-H1488.
17. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS: Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 2000;275:8508-8514.
18. Kishimoto T, Pearse RV, Lin CR, Rosenfeld MG: A sauvagine/corticotrophin- releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995;92:1108-1112.
19. Wiley KE, Davenport AP: CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol 2004;143:508-514.
20. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP: Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000;24:403-409.
21. Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, Di Blasio AM, Petraglia F: Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol 2002;173:R9-R14.
22. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A, Genazzani AR, Petraglia F: Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 1999;84:2802-2806.
23. Node K, Fujita M, Kitakaze M, Hori M, Liao JK: Short-term statin therapy improves cardiac function and symptom in patients with idiopathic dilated cardiomyopathy. Circulation 2003;108:839-843.
24. Agnello D, Bertini R, Sacco S, Meazza C, Villa P, Ghezzi P: Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol 1998;275:E757-E762.
25. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E: Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-235.
26. Ridker PM, Rifai N, Lowenthal SP: Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001;103:1191-1193.
27. Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, Nishi H, Inoue N, Yokoyama M: Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 2001;154:87-96.
28. Treasure CB, Klein L, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi S, Cedarholm J, Alexander W: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-487.
29. Takamoto M, Liao JK: Pleiotropic effects of 3-hydoxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Tromb Vasc Biol 2001;21:1712-1719.
30. Liao JK: Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol 2002;86:5-18.
31. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, Yokoyama M: Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003;23:1398-1404.